| Post |
| Pre |
| LA |
|---|
| 4 |
| 6 |
| ME 1 | ME 2 | ME 3 | ME 4 | ME 5 | ME 6 | ME 7 | ME 8 | ME 9 | ME 10 | Total |
|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 139 | 111 | 10 | - | - | 260 |
| - | - | - | - | - | 2 | - | - | - | - | 2 |
| Post |
| Pre |
| LO 1 | LO 2 | LO 3 | LO 4 | LO 5A | LO 5B | LO 6 | Total |
|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - |
| - | - | - | - | - | - | - | - |
| AME |
|---|
| 2 |
| - |
| Post |
| Pre |
| LOP 1 | LOP 2 | LOP 3 | LOP 4 | Total |
|---|---|---|---|---|
| - | - | - | - | - |
| - | - | - | - | - |
| central brain |
|---|
| 1 |
| - |

| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| ME(L) | 260 | 94.2% | -7.02 | 2 | 16.7% |
| Optic-unspecified(L) | 9 | 3.3% | -1.17 | 4 | 33.3% |
| LA(L) | 4 | 1.4% | 0.58 | 6 | 50.0% |
| AME(L) | 2 | 0.7% | -inf | 0 | 0.0% |
| CentralBrain-unspecified | 1 | 0.4% | -inf | 0 | 0.0% |
| upstream partner | # | NT | conns Lat4 | % In | CV |
|---|---|---|---|---|---|
| MeVC3 (R) | 1 | ACh | 62 | 23.2% | 0.0 |
| Cm6 (L) | 21 | GABA | 56 | 21.0% | 0.7 |
| TmY9a (L) | 5 | ACh | 26 | 9.7% | 0.3 |
| Cm5 (L) | 11 | GABA | 18 | 6.7% | 0.5 |
| MeVC5 (R) | 1 | ACh | 12 | 4.5% | 0.0 |
| MeVC25 (L) | 1 | Glu | 12 | 4.5% | 0.0 |
| MeVC20 (L) | 2 | Glu | 10 | 3.7% | 0.4 |
| Cm20 (L) | 4 | GABA | 9 | 3.4% | 1.0 |
| Cm4 (L) | 6 | Glu | 9 | 3.4% | 0.3 |
| Lat2 (L) | 2 | unc | 7 | 2.6% | 0.7 |
| TmY17 (L) | 6 | ACh | 7 | 2.6% | 0.3 |
| MeVP7 (L) | 1 | ACh | 4 | 1.5% | 0.0 |
| Cm14 (L) | 4 | GABA | 4 | 1.5% | 0.0 |
| Tm16 (L) | 1 | ACh | 2 | 0.7% | 0.0 |
| Pm8 (L) | 1 | GABA | 2 | 0.7% | 0.0 |
| Pm12 (L) | 1 | GABA | 2 | 0.7% | 0.0 |
| OA-AL2i4 (L) | 1 | OA | 2 | 0.7% | 0.0 |
| MeVP3 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| Cm12 (L) | 1 | GABA | 1 | 0.4% | 0.0 |
| Mi10 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| Mi19 (L) | 1 | unc | 1 | 0.4% | 0.0 |
| MeVP9 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| Mi15 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| Cm11a (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| Cm16 (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| Tm38 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| aMe9 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| aMe1 (L) | 1 | GABA | 1 | 0.4% | 0.0 |
| MeVP6 (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| MeVPMe5 (R) | 1 | Glu | 1 | 0.4% | 0.0 |
| Cm24 (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| MeTu1 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| aMe10 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| aMe26 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| Lat5 (L) | 1 | unc | 1 | 0.4% | 0.0 |
| MeVPaMe2 (R) | 1 | Glu | 1 | 0.4% | 0.0 |
| MeVPMe12 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| aMe17e (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| aMe17a (L) | 1 | unc | 1 | 0.4% | 0.0 |
| 5-HTPMPV03 (R) | 1 | 5-HT | 1 | 0.4% | 0.0 |